Symbol
| AKT2
| contributors: mct/npt/pgu - updated : 24-08-2017
|
HGNC name
| v-akt murine thymoma viral oncogene homolog 2
|
HGNC id
| 392
|
corresponding disease(s)
|
NIDDM6
|
Other morbid association(s)
|
Type | Gene Modification | Chromosome rearrangement | Protein expression | Protein Function
|
---|
tumoral
|  
|  
| --over
|  
|
in ovarian carcinoma | tumoral
|  
| amplification
|  
|  
|
in ovarian and pancreatic carcinomas | tumoral
| somatic mutation
|  
|  
|  
|
in the kinase domain occuring in a small fraction of common cancers | tumoral
|  
|  
|  
| gain of function
|
associated with the survival of melanoma cells | tumoral
|  
| amplification
|  
|  
|
amplification of AKT1 and/or AKT2 and high-level polysomy were found in lung carcinomas | tumoral
| fusion
|  
|  
|  
|
recurrent BCAM-AKT2 fusion gene leads to a constitutively activated AKT2 fusion kinase in high-grade serous ovarian carcinoma | |
Variant & Polymorphism
|
| |
Candidate gene
Marker
Therapy target
|
System | Type | Disorder | Pubmed |
cancer | brain | glioma/neuroblstoma | |
targeting AKT2 and AKT3 may hold promise for the treatment of patients with gliomas | cardiovascular | atheroma | cardiac | |
argeting AKT2 in macrophages might be beneficial for treating atherosclerosis. |
| | | |
| Akt2-deficient mice showed abnormal elastic fibers and reduced medial thickness in the aortic wall |